Home / PPLPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PPLPHARMA.NS make money? Does PPLPHARMA.NS have pricing power? What's the Earnings Whisper? Will PPLPHARMA.NS profit more as the business scales? What is PPLPHARMA.NS's management track record? Is PPLPHARMA.NS's current price justified?

Piramal Pharma Limited

₹197.73 +$27.85 (+16.39%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹194.43

Day Range

₹193.6₹198.75

Year Range

₹132.3₹231.93

Market Cap

262B

AVG Volume

6.41M

Trailing/Forward PE

-83.43/52.43

PEG ratio

0.35

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

PPLPHARMA.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	22.7B
26 Q4	27.52B
26 Q3	21.4B
26 Q2	20.44B
26 Q1	19.34B
25 Q4	26.64B
25 Q3	22.04B
25 Q2	22.42B
25 Q1	19.51B
24 Q4	24.88B

Net Income (INR) · Q

PPLPHARMA.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	-693.9M
26 Q4	-88.2M
26 Q3	-1.36B
26 Q2	-992.2M
26 Q1	-817M
25 Q4	1.53B
25 Q3	36.8M
25 Q2	225.9M
25 Q1	-886.4M
24 Q4	1.01B

Operating Income (INR) · Q

PPLPHARMA.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	-283.5M
26 Q4	2.42B
26 Q3	-170.1M
26 Q2	-441.5M
26 Q1	-905.8M
25 Q4	3.68B
25 Q3	1.41B
25 Q2	1.49B
25 Q1	199.4M
24 Q4	3.1B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Piramal Pharma Limited

Video analysis: PPLPHARMA.NS

News: PPLPHARMA.NS

Similar companies